Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Feasibility Study of Treatment Type II Endoleaks With ACP-T5: a Novel Approach.

NCT02487290 is registered in ClinicalTrials.gov with TripleMed B.V. as lead sponsor.

NCT NCT02487290
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02487290 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Feasibility Study of Treatment Type II Endoleaks With ACP-T5: a Novel Approach.
Lead sponsor
TripleMed B.V.
Phase
Not applicable
Overall status
Completed
Start date
February 26, 2018
Completion date
December 15, 2020
Enrollment
4 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

abdominal aortic aneurysm